[Special Stock] DXVX Hits Upper Limit on News of Accelerated Obesity Treatment Development↑
Biohealthcare specialist company DXVX has hit the upper price limit (the highest daily price limit).
As of 2:42 PM on the 18th, DXVX is trading at 2,195 KRW, up 506 KRW (29.96%) from the previous trading day.
This rise appears to be driven by news accelerating the development of an oral obesity treatment.
Hot Picks Today
"The Transfer Failed, but 'Ding Dong' Money Came In"... 32.5 Billion Won Financial Incident at Toss Bank
- "They Wouldn't Give It a Second Look When Offered to Ancestors"... MZ Goes Wild for 80-Year-Old Ceremonial Liquor as a Household Must-Have
- [Breaking] Shinsegae Chairman Chung Yongjin Returns as E-Mart CEO
- "Even If He's Handsome, That's a Bit Much"... The "Behavior" That Turns Off 7 in 10 Women
- 'Hangover Legend' Returns After 11 Years... Lee Sunmin Hyung's 'Captain Q' Sells Out
On the same day, DXVX announced that based on previous research results confirming superiority over control substances in late-stage clinical trials, it is currently optimizing its oral GLP (glucagon-like peptide)-1 obesity drug candidate.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
